Viemed Healthcare, Inc. (VMD)
USD 7.07
(0.0%)
USD 7.07
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 98.45 Million USD | 28.33% |
| 2022 | 76.08 Million USD | 23.95% |
| 2021 | 61.38 Million USD | 10.28% |
| 2020 | 55.65 Million USD | 18.96% |
| 2019 | 46.78 Million USD | 48.35% |
| 2018 | 31.53 Million USD | 52.73% |
| 2017 | 20.64 Million USD | 46.44% |
| 2016 | 14.1 Million USD | -15.78% |
| 2015 | 16.74 Million USD | 68.58% |
| 2014 | 9.93 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 29.22 Million USD | 6.71% |
| 2024 Q1 | 27.38 Million USD | 2.28% |
| 2023 Q2 | 23.08 Million USD | 4.51% |
| 2023 Q1 | 22.09 Million USD | 15.16% |
| 2023 Q4 | 26.77 Million USD | 2.67% |
| 2023 Q3 | 26.07 Million USD | 12.95% |
| 2023 FY | 97.63 Million USD | 28.33% |
| 2022 Q3 | 19.89 Million USD | 2.01% |
| 2022 Q4 | 19.18 Million USD | -3.55% |
| 2022 FY | 76.08 Million USD | 23.95% |
| 2022 Q1 | 17.49 Million USD | 17.79% |
| 2022 Q2 | 19.49 Million USD | 11.45% |
| 2021 Q4 | 14.85 Million USD | -3.03% |
| 2021 Q3 | 15.31 Million USD | 2.95% |
| 2021 Q2 | 14.87 Million USD | -8.91% |
| 2021 FY | 61.38 Million USD | 10.28% |
| 2021 Q1 | 16.33 Million USD | 18.23% |
| 2020 Q4 | 13.81 Million USD | -9.17% |
| 2020 FY | 55.65 Million USD | 18.96% |
| 2020 Q3 | 15.21 Million USD | -15.97% |
| 2020 Q2 | 18.1 Million USD | 49.5% |
| 2020 Q1 | 12.1 Million USD | 5.31% |
| 2019 Q1 | 10.71 Million USD | 20.72% |
| 2019 FY | 46.78 Million USD | 48.35% |
| 2019 Q4 | 11.49 Million USD | -22.04% |
| 2019 Q3 | 14.74 Million USD | 0.87% |
| 2019 Q2 | 14.61 Million USD | 36.5% |
| 2018 Q2 | 7.55 Million USD | 15.8% |
| 2018 Q3 | 8.58 Million USD | 13.65% |
| 2018 Q4 | 8.87 Million USD | 3.33% |
| 2018 FY | 31.53 Million USD | 52.73% |
| 2018 Q1 | 6.52 Million USD | -22.5% |
| 2017 FY | 20.64 Million USD | 46.44% |
| 2017 Q2 | 4.7 Million USD | 35.94% |
| 2017 Q1 | 3.46 Million USD | 5771.29% |
| 2017 Q3 | 4.05 Million USD | -13.82% |
| 2017 Q4 | 8.41 Million USD | 107.44% |
| 2016 Q4 | 58.99 Thousand USD | -98.99% |
| 2016 Q3 | 5.84 Million USD | 0.0% |
| 2016 FY | 14.1 Million USD | -15.78% |
| 2015 FY | 16.74 Million USD | 68.58% |
| 2014 FY | 9.93 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -777.165% |
| Cerus Corporation | 143.15 Million USD | 31.226% |
| OrthoPediatrics Corp. | 137.01 Million USD | 28.146% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -766.598% |
| Talis Biomedical Corporation | 67.18 Million USD | -46.538% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -294.664% |
| Inogen, Inc. | 236.08 Million USD | 58.298% |
| Spectral AI, Inc. | 20.86 Million USD | -371.88% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -75.818% |
| CVRx, Inc. | 76.14 Million USD | -29.302% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -2690.621% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -688.318% |
| Orthofix Medical Inc. | 667.42 Million USD | 85.249% |
| Venus Concept Inc. | 80.47 Million USD | -22.338% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -74.013% |
| Bioventus Inc. | 409.91 Million USD | 75.982% |
| BrainsWay Ltd. | 28.01 Million USD | -251.392% |
| Envoy Medical, Inc. | 17.89 Million USD | -450.078% |
| electroCore, Inc. | 32.03 Million USD | -207.368% |
| IceCure Medical Ltd | 16.87 Million USD | -483.391% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -132.025% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -458.344% |
| MaxCyte, Inc. | 84.84 Million USD | -16.039% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -693.223% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1602.94% |
| PAVmed Inc | 64.82 Million USD | -51.87% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -92.75% |
| RxSight, Inc. | 103.85 Million USD | 5.197% |
| Sight Sciences, Inc. | 126.44 Million USD | 22.14% |
| SI-BONE, Inc. | 156.35 Million USD | 37.031% |
| TELA Bio, Inc. | 84.18 Million USD | -16.946% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -40.535% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 51.588% |
| LivaNova PLC | 843.54 Million USD | 88.329% |
| 908 Devices Inc. | 68.08 Million USD | -44.614% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 79.642% |
| Nemaura Medical Inc. | 7.13 Million USD | -1279.125% |
| NeuroPace, Inc. | 75.29 Million USD | -30.755% |
| LENSAR, Inc. | 33.33 Million USD | -195.335% |
| Apyx Medical Corporation | 51.01 Million USD | -92.977% |
| Cutera, Inc. | 197.72 Million USD | 50.207% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -297.292% |
| BioSig Technologies, Inc. | 28.53 Million USD | -245.086% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 48.582% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -173.026% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 88.229% |
| Axonics, Inc. | 270.2 Million USD | 63.563% |
| Outset Medical, Inc. | 198.77 Million USD | 50.469% |
| IRIDEX Corporation | 31.81 Million USD | -209.464% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 45.37% |
| IRadimed Corporation | 30.12 Million USD | -226.839% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1053.926% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1153.652% |
| Telesis Bio, Inc. | 63.48 Million USD | -55.071% |
| Varex Imaging Corporation | 224.8 Million USD | 56.204% |
| Quipt Home Medical Corp. | 148.66 Million USD | 33.776% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -739.828% |
| Pulmonx Corporation | 112.68 Million USD | 12.631% |
| Dynatronics Corporation | 9.9 Million USD | -893.669% |
| Modular Medical, Inc. | 17.52 Million USD | -461.658% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -387.705% |
| Semler Scientific, Inc. | 38.94 Million USD | -152.807% |
| InMode Ltd. | 215.68 Million USD | 54.352% |
| Bruker Corporation | 1.07 Billion USD | 90.853% |
| Cytosorbents Corporation | 48.33 Million USD | -103.681% |
| DexCom, Inc. | 1.69 Billion USD | 94.179% |
| Align Technology, Inc. | 2.07 Billion USD | 95.259% |
| Viveve Medical, Inc. | 22.17 Million USD | -344.022% |
| ZimVie Inc. | 275.12 Million USD | 64.215% |
| Movano Inc. | 29.69 Million USD | -231.603% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 28.278% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1602.94% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -2690.621% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 83.616% |
| Profound Medical Corp. | 33.6 Million USD | -192.987% |
| Insulet Corporation | 939.9 Million USD | 89.525% |
| enVVeno Medical Corporation | 25.23 Million USD | -290.098% |
| Surmodics, Inc. | 98.69 Million USD | 0.247% |
| iCAD, Inc. | 22.22 Million USD | -342.983% |
| Nuwellis, Inc. | 22.61 Million USD | -335.382% |
| Biotricity, Inc. | 17.18 Million USD | -472.916% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 77.92% |
| Aethlon Medical, Inc. | 12.27 Million USD | -701.897% |
| InspireMD, Inc. | 22.95 Million USD | -328.989% |
| PAVmed Inc. | 64.82 Million USD | -51.87% |
| BIOLASE, Inc. | 34.66 Million USD | -184.045% |
| Beyond Air, Inc. | 61.7 Million USD | -59.567% |
| FONAR Corporation | 28.6 Million USD | -244.185% |
| AxoGen, Inc. | 149.33 Million USD | 34.073% |
| Vivani Medical, Inc. | 26.96 Million USD | -265.114% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 44.406% |
| Inari Medical, Inc. | 448.59 Million USD | 78.053% |
| UFP Technologies, Inc. | 58.08 Million USD | -69.486% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1897.991% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -1458.222% |
| Tenon Medical, Inc. | 16.96 Million USD | -480.227% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1231.706% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -123.235% |
| AdaptHealth Corp. | 1.07 Billion USD | 90.867% |
| Sintx Technologies, Inc. | 15.2 Million USD | -547.674% |
| NanoVibronix, Inc. | 4.97 Million USD | -1879.751% |
| Quanterix Corporation | 118.1 Million USD | 16.636% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -739.828% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -581.713% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 74.927% |
| TransMedics Group, Inc. | 182.82 Million USD | 46.148% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -250.803% |
| NeuroMetrix, Inc. | 11.09 Million USD | -787.049% |
| Hyperfine, Inc. | 52.87 Million USD | -86.21% |
| Establishment Labs Holdings Inc. | 172 Million USD | 42.761% |
| Biomerica, Inc. | 6.97 Million USD | -1310.906% |
| Bone Biologics Corporation | 9.42 Million USD | -944.228% |
| AVITA Medical, Inc. | 80.77 Million USD | -21.879% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -854.815% |
| Silk Road Medical, Inc | 186.35 Million USD | 47.17% |